News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Child developmental issues news

Show

From To
Child developmental issues
HIV-positive, exposed children have worse neurodevelopmental outcomes

Children who are HIV-positive or have been exposed to the virus are at increased risk of having poorer outcomes regarding cognitive and motor development compared with children who are HIV-negative and have not been exposed, according to findings ...

Published
19 February 2018
From
Healio
Child developmental issues
HIV-positive women starting antiretrovirals before conception have increased risk of having an infant that is small for gestational age

HIV-positive women who take combination antiretroviral therapy (cART) before conception have an increased risk of having a small for gestational age (SGA) baby, according to

Published
05 February 2018
By
Michael Carter
Treatment for women
NIH Begins Large HIV Treatment Study in Pregnant Women

The National Institutes of Health has launched a large international study to compare the safety and efficacy of three antiretroviral treatment regimens for pregnant women living with HIV and the safety of these regimens for their infants. The study will evaluate the current preferred first-line regimen for pregnant women recommended by the World Health Organization (WHO) and two regimens containing newer antiretroviral drugs that are becoming more widely used.

Published
24 January 2018
From
NIAID press release
Prevention of mother-to-child transmission
BHIVA response to BMJ article on ART in pregnant women living with HIV

We do not support recommendations of "ART in pregnant women living with HIV: a clinical practice guideline" (BMJ, 11/9/17). Other systematic reviews and numerous observational studies show tenofovir to be safe in HIV in pregnancy.

Published
25 September 2017
From
BHIVA
Prevention of mother-to-child transmission
New recommendations aim to help pregnant women with HIV make informed choices

New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, say a panel of international experts in The BMJ today. The panel recommend older drug combinations instead of the most widely used regimens to help reduce the risk of premature birth and neonatal death - which almost all women said they were extremely keen to avoid.

Published
12 September 2017
From
EurekAlert
Child developmental issues
Stillbirth more frequent in women with HIV in UK and Ireland than in general population

The stillbirth rate among women living with HIV in the UK and Ireland from 2007 to 2015 was more than twice that of the general

Published
01 August 2017
By
Carole Leach-Lemens
Prevention of mother-to-child transmission
Adolescents with HIV do better in more prosperous African countries, even with treatment

Adolescents who acquired HIV perinatally were less likely to die, grew faster and had better immune restoration on treatment if they lived in upper-middle income

Published
31 July 2017
By
Carole Leach-Lemens
Treatment for women
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for

Published
25 July 2017
By
Carole Leach-Lemens
Young people
Health problems may increase as young people infected with HIV at birth get older

A Massachusetts General Hospital study has found that US youth infected with HIV around the time of their birth are at higher risk throughout their adolescence and young adulthood for experiencing serious health problems, poor control of the HIV virus or death.

Published
29 March 2017
From
Eurekalert Inf Dis
Child developmental issues
No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer

HIV-negative infants potentially exposed in utero to doses of the HIV protease inhibitor nelfinavir (Viracept) contaminated with the toxic compound ethyl methyl sulfone (EMS) did not have an

Published
10 October 2016
By
Michael Carter
← Prev1...23456...8Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.